Order Article Reprints

Gambaro K, Marques M, McNamara S, Couetoux du Tertre M, Hoffert C, Srivastava A, Schab A, Alcindor T, Langleben A, Sideris L, et al. A Phase II Exploratory Study to Identify Biomarkers Predictive of Clinical Response to Regorafenib in Patients with Metastatic Colorectal Cancer Who Have Failed First-Line Therapy. International Journal of Molecular Sciences. 2024; 25(1):43. https://doi.org/10.3390/ijms25010043

Gambaro, Karen, Maud Marques, Suzan McNamara, Mathilde Couetoux du Tertre, Cyrla Hoffert, Archana Srivastava, Anna Schab, Thierry Alcindor, Adrian Langleben, Lucas Sideris, and et al. 2024. "A Phase II Exploratory Study to Identify Biomarkers Predictive of Clinical Response to Regorafenib in Patients with Metastatic Colorectal Cancer Who Have Failed First-Line Therapy" International Journal of Molecular Sciences 25, no. 1: 43. https://doi.org/10.3390/ijms25010043

Gambaro, K., Marques, M., McNamara, S., Couetoux du Tertre, M., Hoffert, C., Srivastava, A., Schab, A., Alcindor, T., Langleben, A., Sideris, L., Abdelsalam, M., Tehfe, M., Couture, F., Batist, G., & Kavan, P. (2024). A Phase II Exploratory Study to Identify Biomarkers Predictive of Clinical Response to Regorafenib in Patients with Metastatic Colorectal Cancer Who Have Failed First-Line Therapy. International Journal of Molecular Sciences, 25(1), 43. https://doi.org/10.3390/ijms25010043